导师风采
高树庚
个人信息
Personal Information
- 性别：男
- 导师类型：博士生导师
- 职称：主任医师
- 该职称任职时间：20080901
联系方式
Contact Information
- 所属院系：肿瘤医院
- 所属专业：肿瘤学
- 邮箱 : gaoshugeng@cicams.ac.cn
- 工作电话 : 87787150
个人简介
Personal Profile
高树庚，中国协和医科大学医学博士，主任医师、博士研究生导师，北京协和医学院长聘教授，享受国务院特殊津贴专家，国家卫生健康突出贡献中青年专家，全国对口支援新疆先进个人，北京协和医学院教学名师。现任国家癌症中心副主任、中国医学科学院肿瘤医院副院长。担任中华医学会胸心血管外科分会副主任委员兼秘书长、中国医师协会胸外科医师分会副会长兼总干事、北京医学会胸外科分会主任委员兼肺癌学组组长，《Journal of Thoracic Diseases》、《中华胸心血管外科杂志》、《中华胸部外科电子杂志》副主编，《中华外科杂志》、《中华肿瘤杂志》编委等学术职务，入选中国国家健康科普专家库第一批成员名单、AATS会员。
团队简介
Team Profile
待补充更新
- 研究方向Research Directions
早期肺癌精准微创外科新技术的研发；新辅助免疫治疗在非小细胞肺癌患者中的个性化应用
- 在校研究生Current Graduate Students
硕士研究生 3 名，博士研究生 6 名
- 科研项目Research Projects
| # | 项目名称 | 起止日期 | 金额 | 项目类型 | 本人角色 |
|---|---|---|---|---|---|
| 1 | 肺癌手术联合新辅助免疫治疗的评价体系和优选模式研究 | 2021-12-01 —— 2024-11-30 | 2800.0 | 主持在研的国家或省部级科研项目 | 主持者 |
| 2 | 肿瘤微创诊疗一体化医疗器械关键技术及应用的研究 | 2021-10-01 —— 2025-12-31 | 3200.0 | 主持在研的国家或省部级科研项目 | 主持者 |
| 3 | 新辅助免疫治疗非小细胞肺癌患者ctDNA甲基化动态演变研究 | 2023-01-01 —— 2026-12-31 | 70.6 | 主持在研的国家或省部级科研项目 | 主持者 |
| 4 | 高龄患者周围 型早期非小细胞肺癌外科手术方式探索的多中心前瞻性临床研究 | 2022-05-06 —— 2027-05-01 | 100.0 | 主持在研的国家或省部级科研项目 | 主持者 |
- 发表论文Papers
| # | 论文题目 | 期刊名称 | 发表年份 | 论文署名 |
|---|---|---|---|---|
| 1 | Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection | Annals of Translational Medicine | 2022-05-31 | 高树庚 |
| 2 | Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma | Nature Communications | 2022-05-31 | 高树庚 |
| 3 | Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodes | npj Precision Oncology | 2022-05-31 | 高树庚 |
| 4 | Clinical outcomes following an initial experience with a novel powered vascular stapler in video-assisted thoracoscopic lobectomies: results of a Chinese multi-center study | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 5 | Society for Translational Medicine Expert Consensus on the prevention and treatment of postoperative pulmonary infection in esophageal cancer patients | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 6 | mTOR up-regulation of BEX4 promotes lung adenocarcinoma cell proliferation by potentiating OCT4 | Biochemical and Biophysical Research Communications | 2022-05-31 | 高树庚 |
| 7 | Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study | EbioMedicine | 2022-05-31 | 高树庚 |
| 8 | Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade | npj Precision Oncology | 2022-05-31 | 高树庚 |
| 9 | Severe hypoglycemia and finger clubbing in a patient with a BRCA1 mutation in a solitary fibrous tumor: a case report | Annals of Translational Medicine | 2022-05-31 | 高树庚 |
| 10 | Preoperative systemic immune-inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma | Translational Lung Cancer Research | 2022-05-31 | 高树庚 |
| 11 | Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma | Frontiers in Oncology | 2022-05-31 | 高树庚 |
| 12 | Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 13 | A rare case of primary pulmonary inflammatory pseudotumor-like follicular dendritic cell sarcoma successfully treated by lobectomy | Annals of Translational Medicine | 2022-05-31 | 高树庚 |
| 14 | Uniportal versus multiportal thoracoscopic sleeve lobectomy for the surgical treatment of centrally located lung cancer: a single institution experience | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 15 | Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma | Cancer Immunology Immunotherapy | 2022-05-31 | 高树庚 |
| 16 | Programmed cell death ligand 1 expression in esophageal squamous cell carcinoma: a comparative analysis of three different assays | Chinese Medical Journal | 2022-05-31 | 高树庚 |
| 17 | Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma | Frontiers in immunology | 2022-05-31 | 高树庚 |
| 18 | The value of multidisciplinary team (MDT) management in the diagnosis and treatment of primary intrathoracic synovial sarcomas: a single-center experience | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 19 | Prognostic value of tumor-infiltrating lymphocytes in esophageal cancer: an updated meta-analysis of 30 studies with 5,122 patients | Annals of Translational Medicine | 2022-05-31 | 高树庚 |
| 20 | Neoadjuvant PD-1 inhibitor (Sintilimab) in Non-Small Cell Lung Cancer | Journal of Thoracic Oncology | 2022-05-31 | 高树庚 |
| 21 | Lung Cancer in People’s Republic of China | Journal of Thoracic Oncology | 2022-05-31 | 高树庚 |
| 22 | Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma | International Immunopharmacology | 2022-05-31 | 高树庚 |
| 23 | Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers | Frontiers in Molecular Biosciences | 2022-05-31 | 高树庚 |
| 24 | Three-dimensional reconstruction/personalized three-dimensional printed model for thoracoscopic anatomical partial-lobectomy in stage I lung cancer: a retrospective study | Translational Lung Cancer Research | 2022-05-31 | 高树庚 |
| 25 | Bleeding is the most common cause of unplanned return to operating room after lung cancer surgeries | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 26 | Esophageal Squamous Cell Carcinoma Involving the Lip, Back and Hip | Journal of Thoracic Oncology | 2022-05-31 | 高树庚 |
| 27 | Clinicopathologic Correlation With Expression of PD-L1 on Both Tumor Cells and Tumor-infiltrating Immune Cells in Patients With Non–Small Cell Lung Cancer | Journal of Immunotherapy | 2022-05-31 | 高树庚 |
| 28 | Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients | Thoracic Cancer | 2022-05-31 | 高树庚 |
| 29 | Long-term outcomes and prognostic factors of patients with surgically treated pulmonary atypical carcinoid tumors: our institutional experience with 68 patients | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 30 | Clinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 31 | The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 32 | The Society for Translational Medicine: clinical practice guidelines for mechanical ventilation management for patients undergoing lobectomy | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 33 | Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression | Oncotarget | 2022-05-31 | 高树庚 |
| 34 | Unilateral absence of pulmonary artery associated with contralateral lung cancer | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 35 | Systematic Review and Meta-analysis of Atrial Fibrillation Prophylaxis After Lung Surgery | J Cardiovasc Pharmacol | 2022-05-31 | 高树庚 |
| 36 | Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma | Journal of Cancer | 2022-05-31 | 高树庚 |
| 37 | Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics | DNA and Cell Biology | 2022-05-31 | 高树庚 |
| 38 | Development and validation of an immune‐related prognostic signature in lung adenocarcinoma | Cancer Medicine | 2022-05-31 | 高树庚 |
| 39 | Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis | Gene | 2022-05-31 | 高树庚 |
| 40 | The？powered？vascular？staple？(PVS)？versus？conventional？powered？linier？cutter？(PLC) for the？application？of？bronchial？transection？in？thoracoscopic？anatomic？segmentectomy | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 41 | Clinicopathological features and prognosis of ciliated muconodular papillary tumor | Journal of Cardiothoracic Surgery | 2022-05-31 | 高树庚 |
| 42 | Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery | Translational？Lung？Cancer？Research | 2022-05-31 | 高树庚 |
| 43 | The role of maintenance therapy in the treatment of elderly non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials | Drug Design, Development and Therapy | 2022-05-31 | 高树庚 |
| 44 | Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trial | Bmj Open | 2022-05-31 | 高树庚 |
| 45 | Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer | Translational Lung Cancer Research | 2022-05-31 | 高树庚 |
| 46 | Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma | Translational Cancer Research | 2022-05-31 | 高树庚 |
| 47 | Prognostic Impact of IGF2BP3 Expression in Patients with Surgically Resected Lung Adenocarcinoma | DNA and Cell Biology | 2022-05-31 | 高树庚 |
| 48 | Uniportal video-assisted thoracic surgery for the treatment of lung cancer: a consensus report from Chinese Society for Thoracic and Cardiovascular Surgery (CSTCVS) and Chinese Association of Thoracic Surgeons (CATS) | Translational Lung Cancer Research | 2022-05-31 | 高树庚 |
| 49 | Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity. | Journal of Translational Medicine | 2022-05-31 | 高树庚 |
| 50 | miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1 | American Journal of Translational Research | 2022-05-31 | 高树庚 |
| 51 | PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies | International Journal of Cancer | 2023-07-02 | 高树庚 |
| 52 | Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection | Molecular Cancer | 2023-07-02 | 高树庚 |
| 53 | A Pan-Cancer Analysis of the Oncogenic Role of WD Repeat Domain 74 in Multiple Tumors | Frontiers in Genetics | 2023-07-02 | 高树庚 |
| 54 | Outcomes and experience of anatomical partial lobectomy | The Journal of Thoracic and Cardiovascular Surgery | 2023-07-02 | 高树庚 |
| 55 | RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer | EbioMedicine | 2023-07-02 | 高树庚 |
| 56 | Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma | EbioMedicine | 2023-07-02 | 高树庚 |
| 57 | ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC | Frontiers in immunology | 2023-07-02 | 高树庚 |
| 58 | Global burden and temporal trends in incidence and mortality of oesophageal cancer | Journal of advanced research | 2023-07-02 | 高树庚 |
| 59 | Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer | Cancer Immunology Immunotherapy | 2023-07-02 | 高树庚 |
| 60 | Reporting guidelines for surgical technique could be improved: a scoping review and a call for action | Journal of clinical epidemiology | 2023-07-02 | 高树庚 |
| 61 | Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study | Journal of translational medicine | 2023-07-02 | 高树庚 |
| 62 | The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016-2030 | Translational Lung Cancer Research | 2023-07-02 | 高树庚 |
| 63 | Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial | Journal of Thoracic Oncology | 2023-07-02 | 高树庚 |
| 64 | Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC | BMC medicine | 2023-07-02 | 高树庚 |
| 65 | Multiple primary lung cancer: Updates of clinical management and genomic features | Frontiers in Oncology | 2023-07-02 | 高树庚 |
| 66 | Single-cell RNA-sequencing data reveals the genetic source of extracellular vesicles in esophageal squamous cell carcinoma | Pharmacological Research | 2023-07-02 | 高树庚 |
| 67 | PVR/TIGIT and PD-L1/PD-1 expression predicts survival and enlightens combined immunotherapy in lung squamous cell carcinoma | Translational Oncology | 2023-07-02 | 高树庚 |
| 68 | Expert consensus on perioperative treatment for non-small cell lung cancer | Translational Lung Cancer Research | 2023-07-02 | 高树庚 |
| 69 | Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling | EbioMedicine | 2023-07-02 | 高树庚 |
| 70 | Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing | Frontiers in immunology | 2023-07-02 | 高树庚 |
| 71 | Three-Year Follow-Up of Neoadjuvant Programmed Cell Death Protein-1 Inhibitor (Sintilimab) in NSCLC | Journal of Thoracic Oncology | 2023-07-02 | 高树庚 |
| 72 | A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes | Translational Lung Cancer Research | 2023-07-02 | 高树庚 |
| 73 | Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501) | Annals of Translational Medicine | 2023-07-02 | 高树庚 |
| 74 | TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma | Thoracic Cancer | 2023-07-02 | 高树庚 |
| 75 | Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma | International Immunopharmacology | 2023-07-02 | 高树庚 |
| 76 | Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma | Frontiers in Oncology | 2022-05-31 | 高树庚 |
| 77 | Evidence on reporting guidelines for surgical technique in clinical disciplines: a scoping review protocol | Gland Surgery | 2022-05-31 | 高树庚 |
| 78 | Lobectomy？vs.？sublobectomy for stage I non-small-cell lung cancer: a meta-analysis | Annals of Translational Medicine | 2022-05-31 | 高树庚 |
| 79 | Primary pulmonary epithelioid malignant peripheral nerve sheath tumor in a child: a case report | Annals of Translational Medicine | 2022-05-31 | 高树庚 |
| 80 | Uniportal video-assisted thoracic surgery could reduce postoperative thorax drainage for lung cancer patients | Thoracic Cancer | 2022-05-31 | 高树庚 |
| 81 | Minimally invasive McKeown esophagectomy with two-field lymph node dissection and manual cervical esophagogastric anastomosis. | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 82 | Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report | Translational Cancer Research | 2022-05-31 | 高树庚 |
| 83 | Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer | Cancer Medicine | 2022-05-31 | 高树庚 |
| 84 | Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1) | Cancer Cell International | 2022-05-31 | 高树庚 |
| 85 | Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC | Nature Communications | 2022-05-31 | 高树庚 |
| 86 | Uniportal video‐assisted thoracoscopic left pneumonectomy: Retrospective analysis of eighteen consecutive patients from a single center | Thoracic Cancer | 2022-05-31 | 高树庚 |
| 87 | Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics | Journal of Cancer Research and Clinical Oncology？ | 2022-05-31 | 高树庚 |
| 88 | Development of a predictive nomogram for cause-specific mortality in surgically resected early-stage oesophageal cancer: a Surveillance, Epidemiology, and End Results (SEER) analysis | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 89 | Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer | Journal of Immunotherapy | 2022-05-31 | 高树庚 |
| 90 | Clinicopathological characteristics and prognosis of lung cancer in young patients aged 30 years and younger | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 91 | Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions. | Molecular Oncology | 2022-05-31 | 高树庚 |
| 92 | Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC | Frontiers in Oncology | 2022-05-31 | 高树庚 |
| 93 | Comparison of surgical difficulty in patients with resectable non-small cell lung cancer under different neoadjuvant treatment modes: a retrospective cohort study | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 94 | Identification of prognostic genes in lung adenocarcinoma immune microenvironment | Chinese Medical Journal | 2022-05-31 | 高树庚 |
| 95 | Ultrathin endoscopy versus computed tomography in the detection of anastomotic leak in the early period after esophagectomy | Surgical Oncology | 2022-05-31 | 高树庚 |
| 96 | Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China | Annals of Thoracic Sugery | 2022-05-31 | 高树庚 |
| 97 | Diagnosis, treatment, and prognosis of bronchopulmonary carcinoid: an analysis of 74 patients | Anti-Cancer Drugs | 2022-05-31 | 高树庚 |
| 98 | Characteristics and Surgical Outcomes for Primary Malignant Melanoma of the Esophagus | Scientific Reports | 2022-05-31 | 高树庚 |
| 99 | BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma | PLoS One | 2022-05-31 | 高树庚 |
| 100 | A multi-center evaluation of a powered surgical stapler in video-assisted thoracoscopic lung resection procedures in China | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 101 | Robot-assisted thoracic surgery versus open thoracic surgery for lung cancer: a system review and meta-analysis | International Journal of Clinical and Experimental Medicine | 2022-05-31 | 高树庚 |
| 102 | Partial？esophagogastrostomy？with？esophagogastric？anastomosis？below？the？aortic？arch？in？cardiac？carcinoma:？characteristics？and？treatment？of？postoperative？anastomotic？leakage | Journal of Thoracic Disease | 2022-05-31 | 高树庚 |
| 103 | Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma | Cancer Science | 2022-05-31 | 高树庚 |
| 104 | Developing the surgical technique reporting checklist and standards: a study protocol | Gland Surgery | 2022-05-31 | 高树庚 |
| 105 | The effectiveness of three-dimensional reconstruction in the localization of multiple nodules in lung specimens: a prospective cohort study | Translational Lung Cancer Research | 2022-05-31 | 高树庚 |
| 106 | Treatment outcomes of patients with tracheobronchial mucoepidermoid carcinoma compared with those with adenoid cystic carcinoma | European Journal of Surgical Oncology | 2022-05-31 | 高树庚 |
| 107 | Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization | Nature Communications | 2024-02 | 通讯作者 |
| 108 | Genomic characteristics and immune landscape of super multiple primary lung cancer | EbioMedicine | 2024-02 | 通讯作者 |
| 109 | Plasma extracellular vesicle long RNAs predict response to neoadjuvant immunotherapy and survival in patients with non-small cell lung cancer | Pharmacological Research | 2023-10 | 通讯作者 |
| 110 | Single-cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer | Clinical and translational medicine | 2023-10 | 通讯作者 |
| 111 | Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma | Molecular Cancer | 2024-05 | 通讯作者 |
- 科研获奖Research Awards
| # | 获奖证书编号 | 奖项名称 | 获奖级别 | 获奖类别 | 获奖等级 | 获奖日期 | 颁奖单位 | 本单位是否为第一完成单位 | 完成单位排名 | 本人排序 | 备注 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2017011182P1503 | 肺癌个体化微创根治相关技术的系统研究及临床应用推广 | 省部级 | 其他省部级奖励 | 一等奖 | 2017-11-18 | 中国医疗保健国际交流促进会 | 否 | 3 | 3 | |
| 2 | 2018-J-253-2-02-R04 | 肺癌微创治疗体系及关键技术的研究与推广 | 国家级 | 国家最高科学技术奖、自然科学奖、技术发明奖、科技进步奖 | 二等奖 | 2018-12-12 | 中华人民共和国国务院 | 否 | 4 | 4 | |
| 3 | 2017011194P1504 | 肺癌个体化微创根治相关技术的系统研究及临床应用推广 | 省部级 | 其他省部级奖励 | 一等奖 | 2018-01-22 | 中华医学会 | 否 | 4 | 4 |
- 研究成果Research Findings
| # | 成果类型 | 项目/专利/新品种名称 |
|---|---|---|
| 1 | 作为主创人员获得授权的发明专利和新品种 | 一种锆瓷手术电极 |
| 2 | 作为主创人员获得授权的发明专利和新品种 | 用于肺癌诊断的试剂盒、装置及方法 |
| 3 | 作为主创人员获得授权的发明专利和新品种 | 一种用于预测肿瘤突变负荷的核酸组合物及其方法和设备 |
| 4 | 作为主创人员获得授权的发明专利和新品种 | 外周血甲基化基因及IDH1联合检测诊断肺癌模型 |
| 5 | 出版高水平专著 | 胸外科热点问题专家评论 |
| 6 | 出版高水平专著 | 应对食管癌专家谈 |
| 7 | 出版高水平专著 | Esophageal Cancer |
| 8 | 出版高水平专著 | Segmentectomy for Thoracic Diseases |